Infectious Diseases

Investigators in the Division of Research have a long history in the study of emerging and chronic infections, with studies on cervical cancer screening and human papillomavirus (HPV) vaccination; the treatment, care, and outcomes for people with human immunodeficiency virus (HIV); as well as tuberculosis, vaccine-preventable diseases, and SARS-CoV-2 and COVID-19.

Same sex couple embracing

HIV/AIDS

Researchers in the infectious diseases section focus on HIV prevention, linkage and retention in care, tolerability of antiretroviral therapy, and outcomes, including the risk of age-related comorbidities such as cancer and cardiovascular disease.

Learn more

Two teens sitting on skateboards

Human Papillomavirus

DOR researchers focus on cervical cancer prevention and the epidemiology of other HPV-related cancers, including anal and oropharyngeal cancers.

Learn more

Nurse giving vaccination to man

COVID-19

DOR investigators have been active in evaluating treatments for COVID-19 disease, along with tracking hospital care and other trends for these patients. They have also been involved with  COVID-19 vaccine development, effectiveness evaluation, and safety surveillance.

Learn more

Man sitting on couch looking at mobile phone

Tuberculosis

DOR investigators are working to improve identification, diagnosis, prevention, and control of tuberculosis disease and latent infection.

Learn more

Nurse giving vaccination to child

Vaccine Study Center

The Vaccine Study Center (VSC) helps ensure that the nation’s vaccines are safe and effective by conducting research to advance scientific understanding of vaccines at all levels of development.

Learn more

Infectious Diseases Research Updates

First-ever Infectious Diseases/HIV Research Symposium scheduled for September 27, 2024

Kaiser Permanente Northern California researchers and clinicians from The Permanente Medical Group will highlight research to improve care for KP members at the first-ever 2024 ID/HIV Research Symposium on Friday, September 27, from 8:30 am to 2 pm. This one-day hybrid event will take place in-person at Rosewood Commons in Pleasanton (please note change in location) and virtually on Teams. Sign up HERE.

Scientists

Publications

Research published by Infectious Diseases investigators.

Go to Publications

Studies

Research projects by Infectious Diseases investigators.

Go to Studies

Related Stories

Image for COVID may trigger chronic fatigue syndrome story

COVID may trigger chronic fatigue syndrome

September 18, 2024

A study following Kaiser Permanente Northern California patients with symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in 2022 found 14% of them developed symptoms after having COVID.
Image for Researchers urge bundled screening for TB and chronic hepatitis B story

Researchers urge bundled screening for TB and chronic hepatitis B

September 9, 2024

Focused testing for tuberculosis (TB) and chronic hepatitis B infection of patients who were born outside the United States in countries with high TB and hepatitis B burden could identify many patients who may need prevention or treatment.
Image for Antiviral medications that treat hepatitis C improve long-term outcomes story

Antiviral medications that treat hepatitis C improve long-term outcomes

June 17, 2024

New Kaiser Permanente study identifies some patients cured of hepatitis C who may not require semi-annual surveillance for liver cancer.
Image for Emailed letters can encourage people who have had a heart attack to get the flu shot story

Emailed letters can encourage people who have had a heart attack to get the flu shot

April 11, 2024

People who have had a heart attack responded better to an emailed flu shot reminder that explained the heart health benefits of the vaccine than to letters touting other reasons to get vaccinated.

All spotlight stories >

Infectious Diseases
Back To Top